Job description
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work we perform. In return, we’ll help you build a career that you can feel passionate about.
Job Summary
The Bioscience Division provides support to the pharmaceutical, veterinary pharmaceutical and chemical/agrochemical industries by evaluating the metabolism, distribution and elimination (ADME) of new chemical and biological entities both in vitro and in vivo in a variety of test species.
- Accurate and detailed documentation of activities
- Generation of critical electronic data
- Assisting with the preparation of data and reports for issue to clients
- Engagement in staff training and development programs
- Supervision of junior staff (where required)
Applicants should be educated to degree level ideally in a life science or chemistry related discipline with a significant biology or chemistry component and some degree of mathematics. Relevant laboratory experience in the conduct of regulatory studies would be advantageous, however, full training will be provided.
Specific criteria that you are required to meet include:
1. Relevant qualifications, specifically a minimum of a scientific degree in a relevant discipline.
2. A strong eye for detail and excellent documentation skills.
3. Excellent communication, organisation and time management skills as well as an ability to work flexibly and to tight deadlines
4. A working knowledge of Microsoft Office or scheduling software would be beneficial.
Salary is £26,244.91 per annum.
The closing date is 12 May 2023.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state-of-the-art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 300 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.